Innovating chemistry

Philochem is a Swiss subsidiary of the Philogen group, acting as discovery center with a focus on chemical pharmaceutical products and technologies. Philochem also offers its encoded library technologies to discover small molecule-, peptide-, and antibody-binders to collaboration partners.

Philogen to attend the TIDES Europe 2022 in Vienna, Austria (16-18 November)

Philogen will attend the TIDES Europe in Vienna in November 2022. Samuele Cazzamalli, Head of Small Molecules Therapeutics at Philogen, will give a lecture entitled...

Philogen to attend the PEGS Europe 2022 on November 14-16, 2022

Dario Neri, co-founder, CEO and CSO, is giving a lecture entitled “Antibody-cytokine fusions: emerging clinical data in glioblastoma, sarcoma and dermato-oncology...


Learn about our strategy


Learn more about our pipeline


Look at open positions